SShort S.32· Tech · 10 sources · 3dStoryBasecamp Research Raises $140M for AI TherapiesBasecamp Research announced a $140 million Series C funding, led by S32 with broad participation from tech and philanthropic investors, to train a new generation of EDEN models and advance its AI-designed therapeutics including in vivo cell therapies, while expanding pharmaceutical partnerships. Andy Conrad of Section 32 will join Basecamp’s board as the round underscored the round’s oversubscribed nature and investor confidence in AI-driven drug design.Tech· 3d